Review of NICE Technology Appraisal Guidance Nos. 47 glycoprotein iib/iiia inhibitors in the treatment of acute coronary syndromes & 80 clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome

Review Decision - October 2007

Following consultation, the majority of comments received have led to the decision that the existing guidance on glycoprotein iib/iiia inhibitors in the treatment of acute coronary syndromes (TA No. 47), and clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome (TA No. 80), should be updated by the NICE guideline on acute coronary syndromes, which has recently been referred to the Institute. The current appraisal guidances will stand until the time that the new guideline is issued to the NHS, at this point these technology appraisals will be superseded.

The responses to the review proposal consultation can be found in the link below.

18 January 2007

Table of comments